These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3179575)

  • 1. Influence of temperature on the release of plasminogen activator.
    Fracasso JF; Rodrigues LA; Yashuda Y
    Braz J Med Biol Res; 1988; 21(1):31-3. PubMed ID: 3179575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of the initial level of plasminogen activator in changes in fibrinolysis].
    Andreenko GV; Liutova LV; Karabasova MA; Podorol'skaia LV; Serebriakova TN
    Fiziol Zh SSSR Im I M Sechenova; 1983 Mar; 69(3):380-5. PubMed ID: 6343132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacological potentials for activating the fibrinolytic system].
    Markwardt F
    Z Gesamte Inn Med; 1984 May; 39(10):209-13. PubMed ID: 6380126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperlipemia, fibrinolysis and arteriosclerosis.
    Padró T; Villaverde CA; Cánovas M
    Thromb Res; 1988 Mar; 49(6):519-30. PubMed ID: 3388309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Index of fibrinolysis with new fibrin plate (author's transl)].
    Hishikawa Y; Sugie I
    Nihon Seirigaku Zasshi; 1977; 39(1):1-11. PubMed ID: 140239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrinsic plasminogen activator: a new principle in fibrinolysis.
    Lijnen HR
    Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [State of the fibrinolytic and kinin systems of the blood after physical loading].
    Andreenko GV; Liutova LV; Beniumova OE
    Fiziol Zh SSSR Im I M Sechenova; 1980 Oct; 66(10):1473-80. PubMed ID: 7192224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of moderate and strenuous daily physical activity on fibrinolytic activity of blood: possibility of plasminogen activator stores depletion.
    Keber D; Stegnar M; Keber I; Accetto B
    Thromb Haemost; 1979 Jun; 41(4):745-55. PubMed ID: 483247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of endothelial fibrinolytic activity in aorta and vena cava in rabbits: a fibrin-agar plate method.
    Kamio A; Shiraishi M; Shitama K; Sugimoto Y; Honda K; Takebayashi S
    Artery; 1979 Jan; 5(1):76-89. PubMed ID: 575477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of the vascular plasminogen activator from the pig ear.
    Klöcking HP; Astedt B; Gerlach D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):851-61. PubMed ID: 6083962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities of fibrinolysis in essential hypertension.
    Ettenger MM; MacCarthy EP; Glas-Greenwalt P; Clyne DH; Pollak VE
    J Hypertens Suppl; 1984 Dec; 2(3):S175-8. PubMed ID: 6242555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.
    Camiolo SM; Greco WR
    Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of research into the physiology and pathophysiology of the fibrinolysis system].
    Andreenko GV
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (10):5-19. PubMed ID: 2933082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A lysine-absorbable plasminogen activator is elevated in conditions associated with increased fibrinolytic activity.
    Comp PC; Jacocks RM; Rubenstein C; Radcliffe R
    J Lab Clin Med; 1981 May; 97(5):637-45. PubMed ID: 6783711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunoradiometric determination of blood/tissue plasminogen activators in thrombophilia].
    Astedt B; Fagner U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):475-9. PubMed ID: 6083913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro fibrinolytic activity of recombinant tissue-type plasminogen activator in the plasma of various primate species.
    Lijnen HR; Marafino BJ; Collen D
    Thromb Haemost; 1984 Dec; 52(3):308-10. PubMed ID: 6543405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Disorders in the release of plasminogen activators].
    Brommer EJ
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):198-207. PubMed ID: 2427402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of the enzyme preparation longolytin on fibrinolysis in animals].
    Serebriakova TN; Andreenko GV; Tsymanovich SG; Maksimova RA; Sharkova TS
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (2):66-71. PubMed ID: 3157406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.